07 August 2026
: Case report
[In Press] Pulmonary Actinomycosis Diagnosed via BALF mNGS in a 53-Year-Old Nonsmoking Man With Pneumoconiosis and Penicillin-Induced Thrombocytopenia: A Case Report
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Xin Feng1BE, Lin-yu WangDOI: 10.12659/AJCR.953438
Am J Case Rep In Press; DOI: 10.12659/AJCR.953438
Available online: 2026-08-07, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Pulmonary actinomycosis is an uncommon infection with nonspecific clinical and radiologic features that can be difficult to distinguish from lung malignancy, tuberculosis, and other chronic pulmonary diseases. This report describes a patient with pneumoconiosis in whom bronchoalveolar lavage fluid (BALF) metagenomic next-generation sequencing (mNGS) provided important microbiologic evidence to support the diagnosis of pulmonary actinomycosis after inconclusive conventional evaluation.
CASE REPORT
A 53-year-old nonsmoking presented with a 1-month history of cough and hemoptysis. Chest computed tomography showed bilateral upper-lung masses, multiple nodules, and lymphadenopathy; he initially underwent right upper lobectomy because malignancy was suspected. Histopathologic examination showed necrotizing granulomatous inflammation with carbon deposition, but no specific pathogen was identified. Empirical antituberculosis treatment was ineffective. After transfer to our hospital, bronchoscopy was performed. Routine BALF culture and staining results were negative, whereas mNGS detected Actinomyces israelii. Intravenous ampicillin/sulbactam led to clinical and radiologic improvement, but severe thrombocytopenia developed. Platelet counts decreased again after subsequent penicillin exposure, supporting probable penicillin-induced thrombocytopenia. After discontinuation of penicillin and joint evaluation by respiratory physicians and clinical pharmacists, omadacycline was administered, followed by oral doxycycline. The patient displayed clinical improvement, platelet counts normalized, and follow-up imaging showed lesion absorption.
CONCLUSIONS
This case illustrates the diagnostic difficulty of pulmonary actinomycosis in a patient with pneumoconiosis and suggests that BALF mNGS can be helpful when routine studies are unrevealing. It also indicates that omadacycline is a feasible alternative when penicillin-associated thrombocytopenia prevents continuation of first-line therapy.
Keywords: Pneumoconiosis; Thrombocytopenia; Actinomycosis
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953733
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952819
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952834
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953320
Most Viewed Current Articles
07 Dec 2021 : Case report
22,763,442
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
177,632
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
121,433
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
66,540
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






